EntreMed, Inc.

EntreMed, Inc.

Sector: Commercial Physical And Biological Research Region: MD, United States

: | Nasdaq: ENMD

Similar to: Advanced Cell Technology, Inc., Exelixis, Inc., Medivir AB

EntreMed, Inc. is a clinical-stage pharmaceutical company developing a new generation of multi-mechanism drugs for the treatment of cancer and inflammatory diseases. Its drug candidate, ENMD 2076, which is an Aurora A and angiogenic kinase inhibitor for the treatment of cancer. The company was founded in 1991 and is headquartered in Rockville, MD.

News & Analysis

You may also be interested in: